Published Online: October 1, 2016
Allergic rhinitis (AR) has a major impact on coexisting asthma. Some factors related to loss of asthma control in asthmatic patients with AR have been identified. However, the impact of the severity and treatment of AR on asthma control is poorly understood.
In a recent article by Oka et al published in The Journal of Allergy and Clinical Immunology: In Practice, Matsunaga and colleagues investigated whether the severity and treatment of AR influenced incomplete asthma control in asthmatic patients with AR. This was a cross-sectional study and adult asthmatic patients with AR aged 20 years and older were included. Asthma control status was classified as well or incompletely controlled. According to a validated rhinitis questionnaire, AR severity status was categorized into four groups: Mild intermittent, Moderate/Severe intermittent, Mild persistent, and Moderate/Severe persistent.
The authors found that the incompletely controlled asthma group had greater AR severity and used less nasal corticosteroids (NCSs) than the well-controlled group, even after adjusting for many other factors related to uncontrolled asthma.
Adequate evaluation and treatment of rhinitis in asthmatic patients with AR could lead to better asthma control.
The Journal of Allergy and Clinical Immunology: In Practice is an official journal of the AAAAI, focusing on practical information for the practicing clinician.